| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.203 | 67.481 | 66.549 | 41.188 | 62.472 | 73.926 | 42.874 | 48.858 | 50.950 | 66.291 |
| Total Income - EUR | 56.370 | 67.481 | 66.549 | 41.188 | 62.518 | 73.986 | 43.082 | 48.858 | 50.950 | 66.295 |
| Total Expenses - EUR | 35.726 | 50.495 | 56.427 | 37.486 | 54.783 | 58.423 | 52.753 | 45.592 | 48.781 | 42.457 |
| Gross Profit/Loss - EUR | 20.644 | 16.987 | 10.122 | 3.703 | 7.735 | 15.562 | -9.671 | 3.267 | 2.169 | 23.838 |
| Net Profit/Loss - EUR | 16.405 | 12.914 | 8.196 | 3.291 | 7.110 | 14.823 | -10.102 | 2.778 | 1.659 | 21.850 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Biotech Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 2.075 | 3.940 | 2.598 | 1.627 | 1.364 | 0 | 0 | 0 | 0 |
| Current Assets | 36.695 | 30.213 | 42.429 | 15.250 | 17.398 | 34.360 | 20.281 | 20.469 | 23.010 | 38.086 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 17.686 | 23.177 | 31.259 | 2.428 | 7.748 | 13.353 | 7.848 | 8.155 | 9.404 | 11.295 |
| Cash | 19.009 | 7.037 | 11.170 | 12.822 | 9.650 | 21.008 | 12.433 | 12.314 | 13.606 | 26.791 |
| Shareholders Funds | 21.979 | 18.431 | 13.620 | 8.615 | 15.558 | 30.085 | 19.316 | 5.024 | 6.668 | 28.480 |
| Social Capital | 2.295 | 2.271 | 2.233 | 2.192 | 2.149 | 2.109 | 2.062 | 2.068 | 2.062 | 2.051 |
| Debts | 14.716 | 13.857 | 32.748 | 9.234 | 3.468 | 5.640 | 965 | 15.445 | 16.342 | 9.606 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Biotech Center S.r.l.